Cross comparison and prognostic assessment of breast cancer multigene signatures in a large population-based contemporary clinical series-Reference-Cited by-同舟云学术

Cross comparison and prognostic assessment of breast cancer multigene signatures in a large population-based contemporary clinical series

Published:2019-08-21 Issue:1 Volume:9 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Vallon-Christersson Johan,Häkkinen Jari^ORCID,Hegardt Cecilia,Saal Lao H.^ORCID,Larsson Christer,Ehinger Anna^ORCID,Lindman Henrik,Olofsson Helena,Sjöblom Tobias,Wärnberg Fredrik,Ryden Lisa,Loman Niklas,Malmberg Martin,Borg Åke,Staaf Johan^ORCID

Funder

Cancerfonden

Crafoordska Stiftelsen

Fru Berta Kamprads Stiftelse

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-019-48570-x.pdf

Reference49 articles.

1. Ferlay, J. et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International journal of cancer 136, E359–386, https://doi.org/10.1002/ijc.29210 (2015).

2. Early Breast Cancer Trialists’ Collaborative, G. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365, 1687–1717, https://doi.org/10.1016/S0140-6736(05)66544-0 (2005).

3. Kwa, M., Makris, A. & Esteva, F. J. Clinical utility of gene-expression signatures in early stage breast cancer. Nat Rev Clin Oncol 14, 595–610, https://doi.org/10.1038/nrclinonc.2017.74 (2017).

4. Harris, L. N. et al. Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol 34, 1134–1150, https://doi.org/10.1200/JCO.2015.65.2289 (2016).

5. Cardoso, F. et al. 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer. The New England journal of medicine 375, 717–729, https://doi.org/10.1056/NEJMoa1602253 (2016).

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A triple hormone receptor ER, AR, and VDR signature is a robust prognosis predictor in breast cancer;Breast Cancer Research;2024-09-13

2. Validation of an AI-based solution for breast cancer risk stratification using routine digital histopathology images;Breast Cancer Research;2024-08-14

3. An original study assessing biomarker success rate in breast cancer recurrence biomarker research;BMC Medicine;2024-07-29

4. Selecting postoperative adjuvant systemic therapy for early‐stage breast cancer: An updated assessment and systematic review of leading commercially available gene expression assays;Journal of Surgical Oncology;2024-06-24

5. Molecular subtyping improves breast cancer diagnosis in the Copenhagen Breast Cancer Genomics Study;JCI Insight;2024-04-08